FDA’s GRAS Paradigm Shift: Is Mandatory Notification Lawful Implementation or Regulation by Fiat?
FDA’s proposed rule to eliminate the self-affirmed GRAS pathway faces many practical limitations.
Vitamins & Supplements News
Live Last read · last published · next check
FDA’s proposed rule to eliminate the self-affirmed GRAS pathway faces many practical limitations.
Market growth remains strong as consumers seek evidence-backed botanicals, while industry focuses on quality, transparency, and innovation.

The market is focused on delivering solutions that help people address a range of related issues, including stable glucose levels, satiety, gut health, lean mass, sleep, and metabolic resilience.

Growing consumer interest has created new opportunities for dietary supplement innovation, but also confusion about what qualifies as a legal peptide product.

Formulators are rushing to scale up the supply of naturally derived colors, while flavors are trending toward layered, complex profiles and away from overpowering sweetness.
As the lines between medicine, wellness, and nutrition blur, companies must communicate clearly about what their products are, how they’re made, and the science that supports them.
Genevieve Bruns discusses Jebsen & Jessen Life Science's sourcing strategy and why relationships, integrity, and diversification are more important than ever in today's volatile ingredient market.
Full-spectrum powders and extracts are often positioned as competing options when in reality, they represent different approaches to achieving different outcomes.
Graham Rigby discusses THC restrictions, FDA policy, and the evolving regulatory landscape.

Driven by shifting cultural conversations and greater consumer advocacy, the category is evolving toward life-stage-specific, evidence-based solutions.